Cellaven develops affordable, compact automation for cell culture to accelerate lab research.
Cellaven has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in July 2024.
Cellaven's investors include Bpifrance, DECA-BFC, Finovam Gestion.
Cellaven is headquartered in Dijon, France.
Cellaven develops affordable, compact automation for cell culture to accelerate lab research.
Cellaven is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cellaven — Funding & Investors." VCBacked, July 5, 2024, https://www.vcbacked.co/company/cellaven. Accessed September 14, 2026.
VCBacked. (2024). Cellaven — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/cellaven
{{cite web |title=Cellaven — Funding & Investors |url=https://www.vcbacked.co/company/cellaven |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated